Novel Treatment for Brain Injury

Neurorepair Inc., in cooperation with researchers at the University of California, Irvine, School of Medicine, has developed what is likely the world's most advanced technology for repair of neurological damage, an endeavor heretofore generally thought hopeless. Neurorepair has a highly effective, noninvasive, proceedure that stimulates a massive proliferation, migration and differentiation of new neural cells that can replace those lost to stroke, injury or disease. Neurorepair is the sole owner of this intellectual property and has several pending Patent Applications. The company has no outside shareholders or investors, and no debt. It's research has been privately funded by the founder.

The only current treatment for certain patients who have experienced a stroke is tissue plasminogen activator (tPA), a clot-dissolving agent with a therapeutic window of only a few hours. It is used to treat fewer than 5% of patients. Stroke is the leading cause of long-term disability in the United States, where there are 700,000 strokes each year and more than 4.7 million stroke survivors.